We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AMN Healthcare (AMN) Closes Advanced Medical Acquisition
Read MoreHide Full Article
AMN Healthcare Services, Inc. (AMN - Free Report) recently concluded the Advanced Medical Personnel Services, Inc. buyout (announced previously on Apr 30, 2019). Advanced Medical has garnered a reputation of being an allied and nurse staffing firm, catering to hospitals, schools, clinics, skilled nursing facilities, and home health settings.
Financial Terms
The deal was completed for the previously announced purchase price of $200 million, with up to an additional amount of $20 million that will be paid upon Advanced Medical’s achievement of certain financial results as of Dec 31, 2019.
In order to finance the buyout, AMN Healthcare utilized $51 million in capacity available under its existing secured revolving credit facility. Further, the company amended its credit facility to obtain a new $150 million term loan maturing in June 2024.
Financial Impact of the Acquisition
The buyout will be accretive to AMN Healthcare’s second-quarter 2019 results with estimated revenues of about $5 million.
Advanced Medical is expected to contribute revenues in the range of $70-75 million and around $10 million adjusted EBITDA in the second half of 2019, with fourth-quarter revenues about 15% more than in the third quarter. This is because of the seasonality of Advanced Medical’s school staffing business.
On a combined basis, AMN Healthcare’s income tax rate for the second half of the year is projected to be 30% due to a higher tax rate for Advanced Medical. It will add approximately $0.3 million to depreciation expense in each of the third and fourth quarters.
How is AMN Healthcare Poised to Benefit?
With this buyout, AMN Healthcare will get an opportunity to boost its offerings in some of the rapidly growing and significant care settings. The buyout will help in expanding talent network of healthcare professionals, consequently increasing placement capabilities in the areas where there is most significant imbalances of talent supply and demand.
As part of AMN Healthcare, the combined teams will provide the healthcare industry's most creative and comprehensive services to a broad range of facilities, including schools, where there is a solid requirement for clinicians.
The acquisition has been structured to help the acquirer realize tax benefits with an estimated net present value of $8 million and is projected to be immediately accretive to AMN Healthcare's adjusted earnings per share.
Bright Prospects in Healthcare Staffing Market
Per a report by Grand View Research, the global healthcare staffing market is expected to reach $44.65 billion by 2025 at a CAGR of 6% during the forecast period. Increase in geriatric population can be attributed to demand for healthcare services worldwide. However, it is important to note that there is a shortage of efficient nurses and other healthcare professionals.
Zacks Rank and Share Price Performance
Currently, AMN Healthcare carries a Zacks Rank #3 (Hold). Shares of the company have gained 10.4% in the past three months, against the industry’s decline of 11.9%. Moreover, the stock has outpaced the S&P 500 index’s growth of 0.7%.
Key Picks
Some better-ranked stocks from the broader medical space are Cardiovascular Systems, Inc. , Oxford Immunotec Global PLC and Haemonetics Corporation (HAE - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cardiovascular Systems has earnings growth rate for fiscal fourth quarter of 2019 of 33.3%.
Oxford Immunotec has a long-term earnings growth rate of 25%.
Haemonetics has a long-term earnings growth rate 13.5%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119%and +164%in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
AMN Healthcare (AMN) Closes Advanced Medical Acquisition
AMN Healthcare Services, Inc. (AMN - Free Report) recently concluded the Advanced Medical Personnel Services, Inc. buyout (announced previously on Apr 30, 2019). Advanced Medical has garnered a reputation of being an allied and nurse staffing firm, catering to hospitals, schools, clinics, skilled nursing facilities, and home health settings.
Financial Terms
The deal was completed for the previously announced purchase price of $200 million, with up to an additional amount of $20 million that will be paid upon Advanced Medical’s achievement of certain financial results as of Dec 31, 2019.
In order to finance the buyout, AMN Healthcare utilized $51 million in capacity available under its existing secured revolving credit facility. Further, the company amended its credit facility to obtain a new $150 million term loan maturing in June 2024.
Financial Impact of the Acquisition
The buyout will be accretive to AMN Healthcare’s second-quarter 2019 results with estimated revenues of about $5 million.
Advanced Medical is expected to contribute revenues in the range of $70-75 million and around $10 million adjusted EBITDA in the second half of 2019, with fourth-quarter revenues about 15% more than in the third quarter. This is because of the seasonality of Advanced Medical’s school staffing business.
On a combined basis, AMN Healthcare’s income tax rate for the second half of the year is projected to be 30% due to a higher tax rate for Advanced Medical. It will add approximately $0.3 million to depreciation expense in each of the third and fourth quarters.
How is AMN Healthcare Poised to Benefit?
With this buyout, AMN Healthcare will get an opportunity to boost its offerings in some of the rapidly growing and significant care settings. The buyout will help in expanding talent network of healthcare professionals, consequently increasing placement capabilities in the areas where there is most significant imbalances of talent supply and demand.
As part of AMN Healthcare, the combined teams will provide the healthcare industry's most creative and comprehensive services to a broad range of facilities, including schools, where there is a solid requirement for clinicians.
The acquisition has been structured to help the acquirer realize tax benefits with an estimated net present value of $8 million and is projected to be immediately accretive to AMN Healthcare's adjusted earnings per share.
Bright Prospects in Healthcare Staffing Market
Per a report by Grand View Research, the global healthcare staffing market is expected to reach $44.65 billion by 2025 at a CAGR of 6% during the forecast period. Increase in geriatric population can be attributed to demand for healthcare services worldwide. However, it is important to note that there is a shortage of efficient nurses and other healthcare professionals.
Zacks Rank and Share Price Performance
Currently, AMN Healthcare carries a Zacks Rank #3 (Hold). Shares of the company have gained 10.4% in the past three months, against the industry’s decline of 11.9%. Moreover, the stock has outpaced the S&P 500 index’s growth of 0.7%.
Key Picks
Some better-ranked stocks from the broader medical space are Cardiovascular Systems, Inc. , Oxford Immunotec Global PLC and Haemonetics Corporation (HAE - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Cardiovascular Systems has earnings growth rate for fiscal fourth quarter of 2019 of 33.3%.
Oxford Immunotec has a long-term earnings growth rate of 25%.
Haemonetics has a long-term earnings growth rate 13.5%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119%and +164%in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>